Quantcast
Last updated on April 24, 2014 at 11:28 EDT

Latest Augurex Life Sciences Corp. Stories

2013-10-25 16:23:58

VANCOUVER, Oct. 25, 2013 /PRNewswire/ - Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta biomarkers with scheduled presentations next week at the prestigious American College of Rheumatology Annual Meeting, taking place at the San Diego Convention Center, October 25-30, 2013. World-leading investigators will present data, including a late-breaking study, describing 14-3-3eta's clinical utility for rheumatoid arthritis (RA)...

2012-11-14 16:26:03

VANCOUVER, Nov. 14, 2012 /PRNewswire/ - International arthritis investigators this week at the 2012 Annual Meeting of the American College of Rheumatology held in Washington, DC presented data related to the 14-3-3h protein and its auto-antibodies, a promising set of new blood-based markers from Augurex, that alone or in combination with other markers, may aid in the diagnosis of Rheumatoid Arthritis (RA), a debilitating and chronic autoimmune disease that affects 1.5% of the...

2012-10-09 15:25:06

VANCOUVER, Oct. 9, 2012 /PRNewswire/ - Augurex Life Sciences Corp. today announced that it has formed an exclusive license agreement with Quest Diagnostics, for the development of a clinical laboratory-developed testing service for the U.S. market, based on Augurex's rheumatoid arthritis (RA) 14-3-3h biomarker. Quest Diagnostics is the world's leading diagnostic testing company, and serves approximately half of the physicians and hospitals in the United States. Quest Diagnostics...

2011-05-28 06:00:00

Company's novel biomarker and drug target could represent the first personalized medicine in RA-promise for future targeted therapy in a multi-factorial disease VANCOUVER, May 28, 2011 /PRNewswire/ - Augurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism (EULAR) Conference, leading arthritis researchers presented important data on Augurex's rheumatoid arthritis (RA) biomarker blood test and novel drug target. RA is a disease that...